Buying volume has started to tick up and a few delayed trades coming through. This could be the bottom and now see a steady move up into the afternoon. Feeling rather sick watching this whilst the recovery plays fly on up!
Ive experienced two takeover offer from shares i have been invested in and on both occasions the price was ridiculously low and even though the offer was over double the SP at that time the company rejected both times as they felt the offer was undervaluing the company. I would suspect if a offer came in for £5 it would be pushed back as that is too low a valuation with current forecasts.
Just catching up with the weekend posts also. Some good stuff from the usual reliable posters and then a bit of rumbling in between by you know who. Looking forward to a better week and hopefully some nice suprised in terms of updates. Good luck all genuine holders!
So why has there not been any notification of their holding considering how significant it is? If doesnt fall within french law thats understanable but does that also mean they dont need to notify us as that law would take precedence?
Fair point Brod but i think this market would have been the one they would have tried to tap into from the off. Hence the announcement in March. If they havent managed to make successful inroads since March then i would be very concerned especially considering the amount of testing going on over there. I think Graham has purposely remained very tight lipped on any sort of progress but kept reminding us in the updates that they are pleased with progress over there, almost like subtle hints. Heck! I dont know tbh im a holder and remain optimistic but it could be nothing significant like you say. Lets just sit and hope. Would appreciate any updates from experienced researchers about about other clues available on this?
https://microgenbioproducts.com/pathflow/
Is this the new Exaig test?
Can anyone give anymore insight into the signficance of the Novacyt link with Optigene. It is clear from the government constantly name dropping Optigene that they will be proceeding with this new test as part of the test, track and trace program. In line with recent developments it seems the trial for the lamp test is due to end at roughly the same time we are expected to go live on the track and trace, circa end of June.
I know that NCYT (primers) and Optigene (LAMP master mixers ) have worked together on this but does anyone have any idea if this is conclusive and that we are definetley involved and the potential benefit financially of being involved?
I appreciate our CEO liking posts from Dr Kidd ( Optigene) on linkedin is very reassuring but just wondered if there was anything else anyone knew? Also, i take it this involvement is seperate to the Exsig direct test we are due to launch or could this be the new test linked with optigene? Theres quite a few unknowns at present, hoping someone can shed some more light on.
Finally, What do people think about a potential acquisition of Optigene as an option also? Benefits, drawbacks, considering our financial position.
Its gone down after you bought but if you show patience i almost guarantee you will make a profit. If this doesnt go back to where it belongs in the next month or two i will give investing. The manipulation is unreal!
I wouldnt act on anyones advice and do what is right for you. If you need the money than sell but if you can hold then this will turnaround eventually. Its very uneasing sitging on losses so do what suits your circumstances.
Thing is this was oversold at £3 - £3.50 and people were topping up on dips expecting a surge north as was i. I dont want to put anymore into this now as i just dont know what to expect. Sit, wait and hope is the best most of us can do!